NEWS

Pharmaceutical

Interview: Giovanni Caforio, PhRMA Chairman and CEO of Bristol Myers Squibb

Category: Business News

This year our industry has worked tirelessly to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. At the same time, the nation’s political environment remained turbulent, and systemic societal issues were brought to the forefront, all while we continued to socially distance and readjust our work and personal lives around the pandemic.  

Source: PhRMA

Published: October 25, 2021


More

LMI: Produserer vaksiner på harde livet

Category: Business News

– Vi har fått inn 18 500 nye doser av pneumokokkvaksinen vår til Norge, etter å ha satt alle mann på dekk for å få det til. I forbindelse med COVID-19 har Folkehelseinstituttet understreket sin anbefaling om at eldre og personer med nedsatt immunforsvar bør ta vaksine mot lungebetennelse. Mange nordmenn ønsket å følge rådet, og […]

Source: LMI


More

Aftenposten: Ny Roche koronatest åpner for massetesting i Norge

Category: Business News

Den første av to nye maskiner som gjør det mulig å teste langt flere nordmenn for koronasmitte, ble fredag satt opp ved Oslo universitetssykehus på Ullevål. Den andre Sveits-produserte maskinen kommer til Norge fra Tyskland mandag. Den skal stå ved Akershus universitetssykehus (Ahus). Dette er et nytt og svært viktig bidrag i kampen mot koronaepidemien […]

Source: Aftenposten


More

Press Release: Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company

Category: Business News

NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders. Upon completion of the acquisition, pursuant to the […]

Source: Bristol-Myers Squibb


More

The Top-50 biopharmaceutical investors in the world.

Business

Category: Health

The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D. The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn […]

Source: Health Informatics


More
Page 1 of 5
1 2 3 4 5